<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report an anaphylactic reaction in a 45-year-old gentleman with an 8-year history of extensively treated, relapsing follicular <z:hpo ids='HP_0002665'>lymphoma</z:hpo> who was receiving a second treatment with ibritumomab tiuxetan </plain></SENT>
<SENT sid="1" pm="."><plain>Within seconds of receiving Y-90 ibritumomab, he developed chest tightness, shallow respirations, <z:hpo ids='HP_0002615'>hypotension</z:hpo>, and <z:e sem="disease" ids="C0021167" disease_type="Disease or Syndrome" abbrv="">incontinence</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>After successful resuscitation, a human antimouse antibody (HAMA) level was found to be elevated, 618 ng/mL (reference 0-188 ng/mL) </plain></SENT>
</text></document>